BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

330 related articles for article (PubMed ID: 18477425)

  • 21. Crystal methamphetamine smoking among regular ecstasy users in Australia: increases in use and associations with harm.
    Kinner SA; Degenhardt L
    Drug Alcohol Rev; 2008 May; 27(3):292-300. PubMed ID: 18368611
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A 'real bad' drug.
    Smith SD
    Minn Med; 2005 Aug; 88(8):6-7. PubMed ID: 16225323
    [No Abstract]   [Full Text] [Related]  

  • 23. Dental disease prevalence among methamphetamine and heroin users in an urban setting: a pilot study.
    Brown C; Krishnan S; Hursh K; Yu M; Johnson P; Page K; Shiboski CH
    J Am Dent Assoc; 2012 Sep; 143(9):992-1001. PubMed ID: 22942146
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Memory impairment in methamphetamine dependent patients.
    Moon M; Do KS; Park J; Kim D
    Int J Neurosci; 2007 Jan; 117(1):1-9. PubMed ID: 17365096
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Structural and metabolic brain changes in the striatum associated with methamphetamine abuse.
    Chang L; Alicata D; Ernst T; Volkow N
    Addiction; 2007 Apr; 102 Suppl 1():16-32. PubMed ID: 17493050
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Methamphetamine abuse and dentistry: a review of the literature and presentation of a clinical case.
    Goodchild JH; Donaldson M
    Quintessence Int; 2007; 38(7):583-90. PubMed ID: 17694215
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Methamphetamine and cardiovascular pathology: a review of the evidence.
    Kaye S; McKetin R; Duflou J; Darke S
    Addiction; 2007 Aug; 102(8):1204-11. PubMed ID: 17565561
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Risk and protective factors for nonmedical use of prescription stimulants and methamphetamine among adolescents.
    Herman-Stahl MA; Krebs CP; Kroutil LA; Heller DC
    J Adolesc Health; 2006 Sep; 39(3):374-80. PubMed ID: 16919799
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Risk and protective factors for methamphetamine use and nonmedical use of prescription stimulants among young adults aged 18 to 25.
    Herman-Stahl MA; Krebs CP; Kroutil LA; Heller DC
    Addict Behav; 2007 May; 32(5):1003-15. PubMed ID: 16920275
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Methamphetamine use among young adults: health and social consequences.
    Sommers I; Baskin D; Baskin-Sommers A
    Addict Behav; 2006 Aug; 31(8):1469-76. PubMed ID: 16309848
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Socio-demographic factors associated with methamphetamine treatment contact among dependent methamphetamine users in Sydney, Australia.
    McKetin R; Kelly E
    Drug Alcohol Rev; 2007 Mar; 26(2):161-8. PubMed ID: 17364851
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The nature, time course and severity of methamphetamine withdrawal.
    McGregor C; Srisurapanont M; Jittiwutikarn J; Laobhripatr S; Wongtan T; White JM
    Addiction; 2005 Sep; 100(9):1320-9. PubMed ID: 16128721
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Incidence of Parkinson's disease among hospital patients with methamphetamine-use disorders.
    Callaghan RC; Cunningham JK; Sajeev G; Kish SJ
    Mov Disord; 2010 Oct; 25(14):2333-9. PubMed ID: 20737543
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Methamphetamine abuse and emergency department utilization.
    Richards JR; Bretz SW; Johnson EB; Turnipseed SD; Brofeldt BT; Derlet RW
    West J Med; 1999 Apr; 170(4):198-202. PubMed ID: 10344172
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Methamphetamine use is independently associated with recent risky sexual behaviors and adolescent pregnancy.
    Zapata LB; Hillis SD; Marchbanks PA; Curtis KM; Lowry R
    J Sch Health; 2008 Dec; 78(12):641-8. PubMed ID: 19000240
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinical course and outcomes of methamphetamine-dependent adults with psychosis.
    Glasner-Edwards S; Mooney LJ; Marinelli-Casey P; Hillhouse M; Ang A; Rawson R;
    J Subst Abuse Treat; 2008 Dec; 35(4):445-50. PubMed ID: 18294802
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Methamphetamine abuse and oral health: a pilot study of "meth mouth".
    Ravenel MC; Salinas CF; Marlow NM; Slate EH; Evans ZP; Miller PM
    Quintessence Int; 2012 Mar; 43(3):229-37. PubMed ID: 22299123
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Quite a lot of smoke but very limited fire--the use of methamphetamine in Europe.
    Griffiths P; Mravcik V; Lopez D; Klempova D
    Drug Alcohol Rev; 2008 May; 27(3):236-42. PubMed ID: 18368604
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Increasing prevalence of amphetamine--and methamphetamine-induced psychosis].
    Härtel-Petri R; Rodler R; Schmeisser U; Steinmann J; Wolfersdorf M
    Psychiatr Prax; 2005 Jan; 32(1):13-7. PubMed ID: 15633070
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Electrocardiographic abnormalities in methamphetamine abusers.
    Haning W; Goebert D
    Addiction; 2007 Apr; 102 Suppl 1():70-5. PubMed ID: 17493055
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.